Skip to main content

Articles

Page 7 of 7

  1. This study was designed to evaluate the population pharmacokinetics (popPK) of penicillin G in patients with infective endocarditis and establish a dosage regimen based on pharmacokinetic data and clinical out...

    Authors: Toshiaki Komatsu, Takayuki Inomata, Ichiro Watanabe, Masahiro Kobayashi, Hideya Kokubun, Junya Ako and Koichiro Atsuda
    Citation: Journal of Pharmaceutical Health Care and Sciences 2016 2:9
  2. The increased risk of new-onset diabetes with statin use, including high-potency statins, is well known. However, the effects of high-potency statins on HbA1c are unclear. A retrospective cohort study was cond...

    Authors: Nobuhiro Ooba, Shoutarou Tanaka, Yu Yasukawa, Nariyasu Yoshino, Hiroyuki Hayashi, Shinji Hidaka, Toshiichi Seki and Noriyasu Fukuoka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2016 2:8
  3. High-dose methotrexate (HDMTX) is used in the treatment of certain malignancies, including leptomeningeal metastases, systemic non-Hodgkin lymphoma, acute lymphoblastic leukemia, and osteosarcoma. High circula...

    Authors: Tetsuya Kaneko, Takashi Fujioka, Yosuke Suzuki, Yuhki Sato and Hiroki Itoh
    Citation: Journal of Pharmaceutical Health Care and Sciences 2016 2:7
  4. Cisplatin (CDDP) is used as a key anticancer drug for solid cancers, including lung cancer. However, a large quantity of fluid replacement is required to prevent renal dysfunction. This requirement have made o...

    Authors: Junya Sato, Naoto Morikawa, Hiroo Nitanai, Hiromi Nagashima, Satoru Nihei, Kohei Yamauti and Kenzo Kudo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2016 2:6
  5. Atropine sulfate is an anticholinergic agent for treatment of hypertrophic pyloric stenosis and is orally administrated as a triturate with lactose hydrate. Because of the low safety margin of atropine sulfate...

    Authors: Kei Moriyama, Yoichiro Takami, Natsuki Uozumi, Akiko Okuda, Mayumi Yamashita, Rie Yokomizo, Kenichi Shimada, Takashi Egawa, Takehito Kamei and Kazunobu Takayanagi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2016 2:4
  6. Debate continues about the optimal anticoagulation level for elderly Japanese patients with non-valvular atrial fibrillation (NVAF) receiving warfarin. The Japanese Circulation Society guideline has recommende...

    Authors: Atsushi Ohgushi, Takayuki Ohtani, Natsumi Nakayama, Shigeo Asai, Yoshiyuki Ishii, Atsuo Namiki, Manabu Akazawa and Hirotoshi Echizen
    Citation: Journal of Pharmaceutical Health Care and Sciences 2016 2:2
  7. Bisphosphonates (BPs) are potent antiresorptive agents used to treat osteoporosis and the complications associated with malignant bone metastasis. The aim of this study was to evaluate the incidence of bisphos...

    Authors: Mitsuhiro Nakamura, Ryogo Umetsu, Junko Abe, Toshinobu Matsui, Natsumi Ueda, Yamato Kato, Sayaka Sasaoka, Kohei Tahara, Hirofumi Takeuchi and Yasutomi Kinosada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:34
  8. Increasing the use of generic drugs may reduce the growing healthcare spending. Nevertheless, in Japan, the generic drug market share remains low compared to that of European countries and the United States, m...

    Authors: Masanori Suzuki, Motoyasu Kanamori, Tomoaki Hashimoto, Yuji Hashimoto, Ryohkan Funakoshi and Tadanori Sasaki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 2:1
  9. The implementation of a protocol has been associated with improvements in the processes of care in clinical settings. Although stress ulcer prophylaxis is recommended for critically ill patients at high risk, ...

    Authors: Mai Ikemura, Shinji Nakasako, Ryutaro Seo, Takahiro Atsumi, Koichi Ariyoshi and Tohru Hashida
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:33
  10. Pregabalin, a gabapentinoid, is an adjuvant analgesic for treatment of neuropathic pain, but it has serious adverse effects such as somnolence and dizziness, particularly in elderly patients. Although decrease...

    Authors: Akihiro Ohishi, Yugo Chisaki, Daiki Hira, Kazuki Nagasawa and Tomohiro Terada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:30
  11. Concomitant use of clarithromycin (CAM) and rifampicin (RFP) for the treatment of pulmonary Mycobacterium avium complex (MAC) disease affects the systemic concentrations of both drugs due to CYP3A4–related intera...

    Authors: Hitoshi Shimomura, Sena Andachi, Takahiro Aono, Akira Kigure, Yosuke Yamamoto, Atsushi Miyajima, Takashi Hirota, Keiko Imanaka, Toru Majima, Hidenori Masuyama, Koichiro Tatsumi and Takao Aoyama
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:32
  12. Continuous hemodiafiltration (CHDF) is used as renal replacement therapy for critically ill patients with renal failure, and to treat hypercytokinemia. Since CHDF also clears therapeutic agents, drug pharmacok...

    Authors: Gaku Akashita, Yuto Hosaka, Toru Noda, Kazuya Isoda, Tsutomu Shimada, Kazuki Sawamoto, Ken-ichi Miyamoto, Takumi Taniguchi and Yoshimichi Sai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:31
  13. Screening for hepatitis B virus (HBV) infection is recommended worldwide for patients receiving systemic chemotherapy in accordance with clinical guidelines, but compliance varies by country and facility. Aler...

    Authors: Akimasa Sanagawa, Junko Kuroda, Arufumi Shiota, Noriko Kito, Masashi Takemoto, Yoshihiro Kawade, Tetsuo Esaki and Kazunori Kimura
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:29
  14. Febuxostat is a novel xanthine oxidase inhibitor. However, few studies have examined the long-term efficacy and tolerability of febuxostat after switching from allopurinol in hemodialysis (HD) patients. Theref...

    Authors: Satoru Mitsuboshi, Hitoshi Yamada, Kazuhiko Nagai and Hideo Okajima
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:28
  15. The purpose of this study was to highlight concerns with the current pharmacy practice program and suggest aspects for improvement. A further aim of the study was to enhance the educational effects of the prog...

    Authors: Miho Utsumi, Sachi Hirano, Yuki Fujii and Hiroshi Yamamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:27
  16. Maintainance of a stable basal insulin level is important for glycemic control in treatment of diabetes mellitus. Recently introduced insulin degludec has the longest duration of action among basal insulin for...

    Authors: Morihiro Okada, Masae Okada, Jun Nishigami, Naoto Yamaaki, Kenji Furukawa, Kiminori Ohyama, Tsutomu Shimada and Yoshimichi Sai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:26
  17. This study aimed to evaluate the population pharmacokinetics of digoxin in Japanese patients and establish a dosage regimen based on the pharmacokinetic data.

    Authors: Toshiaki Komatsu, Mami Morita, Futaba Miyaji, Takayuki Inomata, Junya Ako and Koichiro Atsuda
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:25
  18. Fluoroquinolones are often used for the treatment of refractory Mycobacterium avium complex (MAC) disease when the clinical efficacy of the recommended regimen, which includes clarithromycin (CAM), rifampicin (RF...

    Authors: Hitoshi Shimomura, Airi Ono, Keiko Imanaka, Toru Majima, Hidenori Masuyama, Tsugumichi Sato and Takao Aoyama
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:24
  19. Drug literature evaluation has been taught at pharmacy schools in the United States, allowing pharmacy students to learn how to read clinical literature critically. In advanced pharmacy practice experiences, p...

    Authors: Naoto Nakagawa, Yuriko Murai, Makiko Yoshida, Hiroyuki Suzuki and Nariyasu Mano
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:23
  20. Pregabalin is a therapeutic drug for neuropathic pain that is associated with somnolence and dizziness. These adverse events are often experienced shortly after initiating pregabalin, and may lead to treatment...

    Authors: Hiroshi Kato, Masayuki Miyazaki, Mio Takeuchi, Hiroaki Tsukuura, Mihoko Sugishita, Yukihiro Noda and Kiyofumi Yamada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:22

    The Erratum to this article has been published in Journal of Pharmaceutical Health Care and Sciences 2016 2:5

  21. We newly proposed that “Furuta method,” a pharmacist intervention guidelines, is a topical ointment therapy that considers the physical properties and moist environment of wounds for pressure ulcer (PU) treatm...

    Authors: Katsunori Furuta, Fumihiro Mizokami, Hitoshi Sasaki and Masato Yasuhara
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:21
  22. Unintended exposure to antitumor agents from an oral medicine may place healthcare workers and patients taking medicine at risk. In this study, the exposure to blister pack by CP (cyclophosphamide) and appropr...

    Authors: Takae Hanada, Yoichiro Takami, Kei Moriyama, Masafumi Oro, Takehiro Ogawa, Hiroko Moriyasu, Yuka Inoue, Asako Kanemitsu, Eiko Kawamoto, Ayaka Nagase, Anna Hamahara, Atsuko Yamamoto, Kenichi Shimada, Masashi Takahashi and Takashi Egawa
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:20
  23. Differences in error rates between pharmacists and nurses in terms of drug confirmation have not been studied. The purpose of this study was to analyze differences in error rates between pharmacists and nurses...

    Authors: Toshikazu Tsuji, Toshihiro Irisa, Shinji Tagawa, Takehiro Kawashiri, Hiroaki Ikesue, Chiyo Kokubu, Akiko Kanaya, Nobuaki Egashira and Satohiro Masuda
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:19
  24. The objective of this study was to clarify the state of national pharmacy practice program in the 6-year course of pharmaceutical education from the students’ point of view. We will suggest the points for impr...

    Authors: Miho Utsumi, Sachi Hirano, Yuki Fujii and Hiroshi Yamamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:18
  25. Enalapril is an antihypertensive medicine that inhibits angiotensin I-converting enzyme (ACE). The present study investigated interactions between enalapril and a fermented milk product (FMP) containing the AC...

    Authors: Machiko Watanabe, Junichi Kurihara, Shigeto Suzuki, Kazuki Nagashima, Hiroyuki Hosono and Fumio Itagaki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:17
  26. Antipsychotics are potent dopamine antagonists used to treat schizophrenia and bipolar disorder. The aim of this study was to evaluate the relationship between antipsychotic drugs and adverse hyperglycemic eve...

    Authors: Yamato Kato, Ryogo Umetsu, Junko Abe, Natsumi Ueda, Yoko Nakayama, Yasutomi Kinosada and Mitsuhiro Nakamura
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:15
  27. The benefit of Ginkgo biloba for the treatment of dementia remains controversial. The aim of this study was to evaluate the efficacy and safety of Ginkgo biloba in patients with dementia in whom administration...

    Authors: Masayuki Hashiguchi, Yuriko Ohta, Mikiko Shimizu, Junya Maruyama and Mayumi Mochizuki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:14
  28. Ibuprofen is known to be efficacious in the treatment of tension-type headache, the most common form of primary headache. A novel tablet formulation of ibuprofen sodium is more rapidly absorbed than standard i...

    Authors: Elias Packman, Rina Leyva and David Kellstein
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:13
  29. Effect of statin therapy has been reported to be associated with patient’s adherence. Atorvastatin was available in Japan as a brand-name product beginning in 2000. The first atorvastatin generics were introdu...

    Authors: Yasunari Mano, Shota Fukushima, Hisayuki Kuroda, Hiroyuki Ohshima, Yoshinori Kato, Kaori Ohuchi, Kayoko Maezawa, Yasuyuki Momose, Shunya Ikeda and Mariko Asahi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:12
  30. There are many reports regarding various medical institutions’ attempts at incident prevention, but the relationship between incident types and impact on patients in drug name errors has not been studied. Ther...

    Authors: Toshikazu Tsuji, Toshihiro Irisa, Shunichi Ohata, Chiyo Kokubu, Akiko Kanaya, Masanori Sueyasu, Nobuaki Egashira and Satohiro Masuda
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:11
  31. Significant precipitation produced by the dilution of diazepam (DZP) injection with an infusion fluid is a great concern for the clinical practice. In this study, the precipitation behavior under different con...

    Authors: Yoshinori Onuki, Naoki Hasegawa, Chihiro Kida, Mayumi Ikegami-Kawai, Masayoshi Tsubuki, Shunsuke Shirozu, Yasuko Obata and Kozo Takayama
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:9
  32. It is important for pharmacists to manage cancer chemotherapy regimens in order to achieve safe treatment. We examined whether there was a useful pharmacoeconomic benefit of compliance the exclusion criteria o...

    Authors: Makoto Hayashi, Akimasa Yamatani, Hiromu Funaki and Kenichi Miyamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:10

    The Erratum to this article has been published in Journal of Pharmaceutical Health Care and Sciences 2016 2:3

  33. Crizotinib, an ATP-competitive receptor tyrosine kinase inhibitor of both anaplastic lymphoma kinase (ALK) and the hepatocyte growth factor receptor, commonly causes several adverse events (AEs). The clinical ...

    Authors: Yasuko Kurata, Narumi Miyauchi, Manabu Suno, Takahiro Ito, Toshiaki Sendo and Katsuyuki Kiura
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:8
  34. It is well known that molecular-targeted drugs, of which sorafenib (Nexavar®) is one, differ from previous anticancer drugs and cause various unusual adverse drug reactions. Treatment with sorafenib causes adv...

    Authors: Makoto Kajizono, Megumu Aoyagi, Yoshihisa Kitamura and Toshiaki Sendo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:6
  35. The lower urinary tract symptoms (LUTS) increases with age and can have a significant effect on the quality of life of the patients. Elderly patients, who are often characterized by a decline in physiological ...

    Authors: Masako Hashimoto, Kanako Hashimoto, Fumihiko Ando, Yoshiaki Kimura, Keisuke Nagase and Kunizo Arai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:7
  36. Tramadol ((±)-TRA) is recommended for the treatment of mild to moderate cancer pain by the World Health Organization. An oral liquid formulation of (±)-TRA is preferable for patients with a compromised swallow...

    Authors: Manabu Suno, Hidenori Ichihara, Takahiro Ishino, Kento Yamamoto and Yuta Yoshizaki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:5
  37. Delirium is an acute change in cognition and concentration that complicates the postoperative course. Patients who suffer delirium after surgery have an increased risk of persistent cognitive impairment, funct...

    Authors: Kiminaka Murakawa, Yoshihisa Kitamura, Saori Watanabe, Shiho Hongo, Kazuaki Shinomiya and Toshiaki Sendo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:4
  38. In the construction of pharmacoeoconomic models, simplicity is desirable for transparency (people can see how the model is built), ease of analysis, validation (how well the model reproduces reality), and desc...

    Authors: Takeshi Uchikura, Makoto Kobayashi, Masayuki Hashiguchi and Mayumi Mochizuki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:3
  39. To improve the adherence to and knowledge about pharmacotherapy in outpatients and to maximize the efficacy and minimize the adverse drug events, the first pharmacist-managed clinic (PMC) in Japan was establis...

    Authors: Kiyofumi Yamada and Toshitaka Nabeshima
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:2

Official journal of JSPHCS

Annual Journal Metrics

  • 2022 Citation Impact
    1.0 - 2-year Impact Factor
    1.3 - 5-year Impact Factor
    0.490 - SNIP (Source Normalized Impact per Paper)
    0.223 - SJR (SCImago Journal Rank)

    2023 Speed
    7 days submission to first editorial decision for all manuscripts (Median)
    88 days submission to accept (Median)

    2023 Usage 
    407,928 downloads
    83 Altmetric mentions